Literature DB >> 7788629

Transcatheter arterial embolization as a method of cisplatin-retention enhancement on the VX2 tumor uterus transplants.

K Harima1, Y Harima, T Hasegawa, Y Tanaka.   

Abstract

PURPOSE: Enhanced cisplatin (Pt) retention using transcatheter arterial chemoembolization (TAE) with Gelfoam particles was studied in rabbit uterine tumors.
METHODS: Ten rabbit uteri were inoculated with 5 x 10(7) cells of VX2 carcinoma. Three to four weeks later cisplatin, 1 mg/kg, was injected, either with (TAE group) or without (IA group) being mixed with small Gelfoam particles, into the aortic bifurcation over 5 s. Blood and tissue concentration of cisplatin were determined.
RESULTS: Slower arterial blood clearance of Pt was observed in the TAE group compared with the IA group, whereas the venous blood Pt clearance curves were similar for both groups. The uterine tumor Pt concentration at 80 min was found to be 2.52-fold higher after TAE compared with IA (p < 0.01). In the pelvic metastatic lymph nodes, the Pt concentration was 4.63 times higher after TAE than after IA (p < 0.01).
CONCLUSION: These data indicate that TAE is an effective means of increasing tissue concentration in uterine tumors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7788629     DOI: 10.1007/bf02807352

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  14 in total

1.  Arteriovenous malformation of the pyriformis muscle manifesting as a sciatic nerve tumor.

Authors:  M D Cusimano; P M Shedden; A R Hudson; J M Bilbao
Journal:  Neurosurgery       Date:  1992-07       Impact factor: 4.654

2.  Internal iliac artery: embolization to control hemorrhage from pelvic neoplasms.

Authors:  J M Pisco; J M Martins; M G Correia
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

3.  The antitumor agent cis-Pt(NH 3 ) 2 Cl 2 : distribution studies and dose calculations for 193m Pt and 195m Pt.

Authors:  R C Lange; R P Spencer; H C Harder
Journal:  J Nucl Med       Date:  1973-04       Impact factor: 10.057

4.  Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.

Authors:  J N Munck; M Riggi; P Rougier; G G Chabot; L H Ramirez; Z Zhao; C Bognel; P Ardouin; P Herait; A Gouyette
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

5.  Collagen chemoembolization: pharmacokinetics and tissue tolerance of cis-diamminedichloroplatinum(II) in porcine liver and rabbit kidney.

Authors:  J R Daniels; M Sternlicht; A M Daniels
Journal:  Cancer Res       Date:  1988-05-01       Impact factor: 12.701

6.  Changes in bone and bone marrow of rabbits bearing the VX-2 carcinoma. A comparison of local and distant effects.

Authors:  A Hough; H Seyberth; J Oates; W Hartmann
Journal:  Am J Pathol       Date:  1977-06       Impact factor: 4.307

7.  Transcatheter arterial embolization therapy in cases of recurrent and advanced gynecologic cancer.

Authors:  Y Harima; T Shiraishi; K Harima; S Sawada; Y Tanaka
Journal:  Cancer       Date:  1989-05-15       Impact factor: 6.860

8.  Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic, and pharmacologic studies.

Authors:  N Jaffe; J Knapp; V P Chuang; S Wallace; A Ayala; J Murray; A Cangir; A Wang; R S Benjamin
Journal:  Cancer       Date:  1983-02-01       Impact factor: 6.860

9.  Pharmacokinetics of intra-arterial chemotherapy.

Authors:  F O Stephens
Journal:  Recent Results Cancer Res       Date:  1983

10.  Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue.

Authors:  N Matsuo; H Uchida; K Nishimine; S Soda; M Oshima; H Nakano; N Nagano; Y Nishimura; T Yoshioka; Q Guo
Journal:  J Vasc Interv Radiol       Date:  1993 Jul-Aug       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.